Biocon granted French inspecting authority’s pre-approval for Biologics Drug Substance facilities

2017-07-11 05:12:55

Biocon has announced that the French inspecting authority (ANSM) conducted pre-approval inspection audits of its Bangalore drug substance and drug product sitesBy team ABLEIndia’s Biotech giant, Biocon has announced that the French inspecting authority (ANSM) conducted pre-approval inspection audits of its Bangalore drug substance and drug product sites related to the pending EMA Marketing Autho

Read more

FDA waves first approval in nearly 20 years for rare blood disorder therapeutic

2017-07-11 05:11:21

Endari is the first treatment approved for patients with sickle cell disease in almost 20 yearsBy Team ABLEThe US Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.“Endari is the first treatment approved for patients with sickle cell disease

Read more

JIGYASA, a Student-Scientist connect program, launched

2017-07-11 05:10:03

Jigyasa is a student-scientist connect program in collaboration with CSIR that helps school students inculcate practical scientific knowledge By Team ABLEJigyasa, a student-scientist connect program was officially launched in the national capital earlier last week. Council of Scientific and Industrial Research (CSIR), has joined hands with Kendriya Vidyalaya Sangathan (KVS) to implement this progr

Read more

Call for Indo-US Genome Engineering/Editing Technology Initiative (GETin) goes on notice board

2017-07-11 05:07:43

DBT and Indo U.S. Science & Technology Forum has announced a call to provide opportunity to Indian students and scientists to gain exposure and access to research facilities in leading US institutions.  By Team ABLEAcknowledging the importance of strategies & techniques in genome modification, as modern day essential tool for research & development, Department of Biotechnology (DB

Read more

India declares itself free from Highly Pathogenic Avian Influenza

2017-07-07 09:38:09

India has declared itself free from Avian Influenza (H5N8 and H5N1) from June 6, 2017 and notified the same to OIE.By Team ABLEIndia had earlier reported outbreaks of Highly Pathogenic Avian influenza at various epicenters in Delhi, Gwalior (MP), Rajpura (Punjab), Hissar (Haryana), Bellary (Karnataka), Allappuzha and Kottayam (Kerala), Ahmedabad (Gujarat), Daman (Daman) and Khordha and Angul (Odis

Read more

Union Minister J P Nadda addresses ‘BRICS Health Ministers’ Meeting at China; highlights the achievements of India in the health sector

2017-07-07 09:32:59

Health Minister J P Nadda said that India stands unwavering in its commitment towards synergizing collaboration with BRICS countries especially through the ‘BRICS Framework for Collaboration on Strategic Projects in Health’By Team ABLE“Strengthening of health systems is critical to achieving the Sustainable Development Goals (SDGs). India has prioritized strengthening health systems as a non

Read more

Lok Sabha speaker inaugurates 4th National Summit on Public Health Care Systems at Indore

2017-07-07 09:29:30

Sumitra Mahajan, Speaker of the 16th Lok Sabha inaugurated the 4th National Summit on Good, Replicable Practices and Innovations in Public Health Care Systems at Indore, Madhya PradeshBy Team ABLEOn July 6, 2017, Ms Sumitra Mahajan, Speaker of the 16th Lok Sabha inaugurated the 4th National Summit on Good, Replicable Practices and Innovations in Public Health Care Systems at Indore, Madhya Pradesh

Read more

Union Minister J P Nadda chairs high level review meeting on control of vector borne diseases

2017-07-07 03:17:09

During the meeting, Minister Nadda asked the States for mounting aggressive IEC campaigns to enhance awareness on prevention and control of vectors in their surrounding areas and neighborhoods. By Team ABLEUnion Minister for Health and Family Welfare J P Nadda, on July 4, 2017, held a high-level meeting to review the preparedness of the Ministry for prevention and control of vector borne dise

Read more

Sun Pharma, Samsung BioLogics join hands to tie-up for Tildrakizumab

2017-07-07 03:11:10

By Team ABLESun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational therapeutic for the treatment of moderate to severe plaque psoriasis.Sun Pharma and South Korea-based Samsung BioLogics have announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma’s wholly-owned subsidiary and Samsung BioLog

Read more

India to grant marketing authorization for BIOCAD’s rituximab biosimilar

2017-07-07 03:09:21

On June 20, 2017, the Central Drugs Standard Control Organization (CDSCO) has recommended Acellbia, the first rituximab biosimilar made in Russia, for approval in India.By Team ABLERussia’s BIOCAD has announced that on June 20, 2017 the company has received a recommendation from the Central Drugs Standard Control Organization (CDSCO) to market its Acellbia, a rituximab biosimilar, for the Indian

Read more